Computational drug discovery: molecular docking, virtual screening, QSAR, cheminformatics and AI-guided drug design.
Researchers from Yale University and other institutions have identified MED6-189 as a new antimalarial drug, a new development that might change the dynamics of malaria treatment. This new compound is active against sensitive and resistant forms of Plasmodium falciparum, which is the most virulent. Malaria, a devastating disease caused by parasitic protozoans of the genus…
Improved computational tools and artificial intelligence significantly improve drug discovery. This process has automated activities like molecular docking and predictive modeling to discover candidates for drugs with enhanced efficiency and a better prospect of correct predictions. Thus, several cheminformatics tools are currently untouchable for those without relevant specialized expertise. What if there was a way…
Determining the function of proteins is one defining aspect of molecular biology that also carries great potential in drug discovery and development. A better comprehension of what the proteins do leads to faster discovery of valuable drug targets, which in turn saves the resources related to laboratory work, the purpose of which is the search…
Target-based drug development depends heavily on characterizing druggable pockets, which are protein areas with the capacity to bind organic small molecules. Nevertheless, the process of obtaining pocket descriptors is complex, and the effectiveness of current approaches is frequently restricted. Researchers present PocketVec, a method for creating pocket descriptors by virtually screening lead-like compounds inversely. PocketVec…
A recently published work by researchers from the Wuhan Textile University, China, and Michigan State University, USA, has addressed the use of transformer models in the context of drug discovery and related domains. Transformers are deep learning models designed primarily for language-based tasks, and their scope is expanding into various scientific areas. This blog post…
Numerous biological processes are regulated by protein-protein interactions (PPIs), and modified PPIs have uses in gene and cell therapy. Here, researchers from the University of Washington present a simple, highly scalable yeast two-hybrid method for assessing PPIs called massively parallel PPI measurement by sequencing (MP3-seq). DNA barcodes in MP3-seq are linked to particular protein pairs,…
ChatMol, an innovative AI model designed by Tsinghua University, PingAn Technology, and Beijing University of Posts and Telecommunications researchers, shapes the contours of the Molecular design revolution. The capacity of ChatMol allows researchers to talk (with) the molecules, thus making the molecular design less complicated and more user-friendly. Molecular design is very important in disciplines…
In a recent study published in Nature Communications, researchers at the University of Washington, University of California, San Francisco, and University of Michigan, along with others, revisited the concept of drug discovery by using an innovative AI-augmented virtual screening tool. Named RosettaVS, this technology merges machine learning approaches with a physical model to provide excellent…
To fight cancer, we must stop their metastasis or uncontrolled multiplication. Hence, it is important to understand what proteins these cancer cells need for growth. Precision medicine is supported by our understanding of the genetic makeup of humans, but the genotype-phenotype relationships remain therapeutically unactionable because of less functional assays and tools. In the rapidly…
Deep learning is being utilized in the course of drug development to understand the structure of the protein-ligand complex, utilizing the technique of virtual structure measurement that combines docking and deep learning despite limitations in accuracy and efficiency. Here, researchers demonstrate that a single multi-task geometric deep learning model, LigPose, can accurately handle these two…
Targeted and efficient treatments for identified protein targets necessitate the use of structure-based drug design (SBDD); this is still a challenge owing to the vast chemical space and complex protein-ligand interactions. The progress of language models (LMs) in NLP is commendable; still, there is much to learn about how LMs can be utilized in SBDD….
The use of artificial intelligence (AI) in all phases of medication development is growing rapidly. Drug pharmacokinetic (PK) datasets are frequently acquired independently of one another, frequently with little overlap, causing data overlap sparsity, which presents a barrier for drug discovery AI. University of Waterloo researchers trying to find answers to questions in poly-pharmacy, medication…
Scientists from McGill University, Genentech, and Université de Montréal have developed GFlowNets, a new way to speed up the process of discovering drugs. Their findings show how one can now generate new drug molecules by considering their impact on cell morphology. The Challenge of Drug Discovery The traditional approach to drug discovery is often a…
Protein design is important for personalized medicine and drug discovery. Generative models for protein structures prove to be especially useful in these areas. Traditional methods of protein design- for example, Rosetta- do this by solving optimization problems for the sequence that minimizes energy functions. Such methods are often effective but can frequently be very computationally…
The goal of de novo protein design (DNPD) is to build novel protein sequences from scratch without using pre-existing protein templates. Nevertheless, existing deep learning-based DNPD methods are sometimes constrained by their concentration on particular or poorly defined protein designs, which prevents more extensive investigation and the identification of a wide range of useful proteins….
Molecular docking, which predicts the binding configurations between ligands and proteins, is an essential step in the drug discovery process. Advances in deep learning-based techniques such as DiffDock have demonstrated improved performance in binding pose prediction. Unfortunately, the lack of a clear scoring mechanism in these methods can make it difficult to distinguish between strong…
Scientists from Tencent Quantum Lab and China Pharmaceutical University, China, introduced an innovative hybrid quantum computing pipeline developed to address the challenges of real-world drug discovery. This new approach is expected to transform the pharmaceutical industry by reducing the time to develop drugs and enhancing therapeutic success. The need to create up-to-date medications for intricate…
The Stony Brook University scientists tied to the Institute of Chemical Biology and Drug Discovery (ICB & DD) discovered that Fatty Acid Binding Proteins (FABPs) are pharmacological targets of the body’s endocannabinoid system licensed to Artelo Biosciences, Inc. Fatty Acid Binding Proteins (FABPs) were identified as potential pharmacological targets for the treatment of cancer, inflammation,…
Recent advances in chemistry, material science, and biological research have been greatly aided by large language models (LLMs), which act as flexible foundation models for various downstream predictive or generative tasks. A team of researchers from Zhejiang University and with their collaborators in China proposed an LLM-based foundation model technique called AMP-Designer as a quick…
A team of scientists from the German Center for Neurodegenerative Diseases (DZNE) and Helmholtz AI have conducted an innovative study that presents DrugDiff — a unique tool to generate new compounds with different desired molecular properties. This tool will change the face of the early stages of drug development by generating fresh small molecules possessing…
Small molecule drug design depends on protein-ligand interactions, and achieving experimental precision necessitates a wide and well-curated dataset. The scarcity of current datasets makes it difficult to realistically evaluate the generalization capabilities of methods and leads to the leakage of training data, underscoring the need for a diversified approach. PLINDER (protein ligand interactions dataset and evaluation resource), the largest and…
In recent years, the integration of artificial intelligence (AI) and machine learning (ML) into various scientific domains has significantly advanced, and chemistry is no exception. LLMs can accurately predict properties, design new molecules, optimize synthesis pathways, and accelerate drug and material discovery. Turning LLMs into agents using chemistry-specific tools such as synthesis planners and databases…
Researchers from the Department of Biological Chemistry at Hebrew University, Jerusalem, and the Department of Pharmaceutical Chemistry at the University of California, San Francisco, have developed a landmark tool to forecast how mutations influence protein interactions. This study by Dr. Julia M Shifman, Dr. William DeGrado, and the team describes ProBASS, a language model that…
In the world of drug discovery, predicting how well a drug molecule will bind to its target is like figuring out the best path on a treasure map when you’re lost. Scientists use complex calculations to predict this binding affinity. One powerful method is called “Absolute Binding Free Energy” (ABFE) calculations. These calculations help scientists…
Evaluating specific properties of molecules from simple SMILE strings isn’t enough. Instead of simple chalkboard formulae, our aim should be to conjure up three-dimensional molecular structures that could fit snugly into tiny pockets within proteins. 3D deep molecular generative models stand out by enabling the generation of molecules based on 3D-dependent properties, such as binding…
A part of systems biology is ‘designing RNA structures,’ which entails planning and organizing molecules of RNA into custom 3D formations with particular uses. RNA plays a dual role in cells, encoding genetic information and performing structural functions. Proteins are somewhat easier to study and model because of the precision nature of this macromolecule, while…
Single-cell technologies are effective drug development and discovery tools, serving important functions at several phases. They aid in identifying potential therapeutic targets, streamline single-cell high-throughput screening, and support pharmacokinetic investigations of anti-tumor medications. New tools for single-cell research combine multiple molecular information, increase the size of data, and characterize the influence of genes on phenotypic…
A web-based tool called Protein Interaction Explorer (PIE) by researchers from Université de Paris, France, was created to support structure-based drug discovery efforts that center on protein-protein interactions (PPIs). PIE is integrated into the database iPPI-DB. Researchers can detect and characterize important variables such as binding pockets, functional binding sites, hot spots, and protein-embedded pockets for…
As the fight against disease has changed, so have therapeutic strategies. One such new approach is Targeted Protein Degradation (TPD), which attempts to exploit the cell’s natural degradation machinery to get rid of unnecessary proteins. The cornerstone of TPD is PROTACs (Proteolysis-Targeting Chimeras); these molecules are very complex and act like Trojan horses that bring…
Improved identification of interactions between proteins and ligands has been invaluable in the progress of computational biology, potentially enhancing drug discovery and revealing more about the molecular world. Traditional approaches tend to utilize structural information, which is sometimes scarce or nonexistent. Enter PSICHIC (PhySIcoCHemICal): a graph convolutional network model, physicochemical and chemotherapeutic interactions in sequence…
Drug discovery requires the fundamental process of molecular property prediction or MPP. However, the shortcomings of previous approaches—crucial for real-world applications—are their limited capacity to generalize for novel and unforeseen jobs and their need for a high number of labeled molecules. The researchers present MolecularGPT for a few-shot MPP to address these issues. Researchers refine…
Researchers at EvolutionaryScale introduced ESM3, an AI-driven language model for the life sciences that enables us to create and program using the universal language of life. In the same way researchers create machinery, structures, and microchips, this breakthrough advances the field of biological engineering from the ground up. ESM3 is very receptive to biological alignment…
The field of medicine has had big news. Scientists from Google Research and Google DeepMind unveil Tx-LLM, a new tool that helps speed up the complex drug discovery process. Tx-LLM is a large language model (LLM) optimized for pharmaceutical development. It is fine-tuned from PaLM-2 and is set to advance LLMs in biochemistry, potentially becoming…
In drug development, the accurate prediction of RNA structures plays a pivotal role. Leveraging the power of machine learning, particularly Variational Autoencoders (VAEs), has emerged as a game-changer in this domain. Recent advancements by Quantori LLC, Cambridge, USA researchers have showcased the superiority of VAE models in RNA folding, surpassing traditional methods with remarkable precision….
Scientists at Westlake University have developed FoldToken2, a novel approach to protein structure representation that is capable of surpassing the coordinates. This innovative method transforms complex 3D protein structures into a series of tokens, like words used in a sentence, to represent key characteristics of protein structure. FoldToken2 works as the Rosetta Stone for proteins,…
Transformers have shown promise in computational biology, but applying them to biological sequences could cause mispredictions in the downstream processes. A greater range of applications and more accurate downstream predictions are possible with three-dimensional (3D) molecule structures because they are more compatible with Transformer architecture and natural language processing models. This fundamental problem is addressed…
It is still very difficult to construct complex protein folds from scratch using only computational methods. École Polytechnique Fédérale de Lausanne (EPFL) scientists create intricate folds and soluble counterparts of essential membrane proteins using a powerful deep-learning pipeline. Researchers show that the structural characteristics of unique membrane topologies, including those from G-protein-coupled receptors, may be…
In the world of molecular design that is constantly evolving, it is always essential to ensure that along with the structure and properties of newly designed compounds appeal to synthetic chemists; there are ways to synthesize the compound. The ability to have cost-aware decision-making algorithms is a novel opportunity with a focus on the qualified…
Understanding the intricate physical interactions between a molecule and its surroundings is necessary to generate unique active molecules for a particular protein, which is a very difficult problem for generative models. In a recent study, scientists from Insilico Medicine and their collaborators introduced a unique generative model called BindGPT that builds 3D molecules inside protein…
Despite the challenge of scaling for large-scale screenings, advances in computational structural biology, like AlphaFold-Multimer, have greatly improved the understanding of protein-protein interactions across entire proteomes, enabling large-scale screenings and elucidating system properties within or between organisms. Here, researchers provide AlphaFastPPi, a pipeline based on AlphaPulldown and AlphaFold-Multimer. AlphaFastPPi is a simplified pipeline that uses…
In a recent scientific breakthrough, a team of researchers from NVIDIA and Innophore, USA, came up with a holistic dataset of the predicted protein folding for each member of the proteome of human beings (the complete set of molecules encoded by human genes), representing a great advancement in protein science. Introduction Life has protein as…
The healthcare industry is about to change significantly due to the advent of generative AI. Meta Llama 3 NIM, a mighty NVIDIA-developed AI microservice, is at the helm of this revolution. This blog post discusses how Meta Llama 3 NIM has started being adopted across various healthcare sectors, involving some pioneering organizations whose competitiveness and…
Significant progress has recently been made in predicting protein sequence to structure; however, modeling protein interfaces and complex structures is still tricky, particularly when binding partners undergo large conformational changes. According to earlier research, in only 43% of cases, AF-multimer (AFm) can accurately predict protein complexes. In this work, Johns Hopkins University researchers combine a…
Artemisinin, which is used as a cure for malaria, has remained an effective drug in managing the disease over the years. However, the recent activity arising from Plasmodium falciparum resistant to artemisinin, an important vital compound used in malaria treatment, is one of the most significant challenges threatening global health. Recent research published in Nature…
Antibiotic resistance is one of the most pressing challenges in modern medicine. As bacteria evolve to withstand our best treatments, once-manageable infections are becoming increasingly difficult, if not impossible, to treat. Among the most notorious of these resistant bacteria are those that resist quinolone antibiotics, a critical class used to treat a variety of infections….
In the ever-changing environment of computational biology, predicting the structure of protein-ligand complexes remains a vital task with far-reaching ramifications for drug development and molecular biology. DynamicBind, a pioneering model described in a Nature Communications paper, is revolutionizing the field of protein-ligand interaction investigations. This novel technique, pioneered by Wei Lu, Jixian Zhang, Shuangjia Zheng,…
Drug discovery is a process known for being slow and expensive. A great number of optimistic molecules disappear in clinical trials while patients wait and researchers become frustrated. Here comes artificial intelligence (AI), which may be a game-changer that is altering our approach to identifying new drugs. However, have these AI-discovered drugs been successful in…
Personalized medicine and effective sequence utilization are made possible by protein design, even in cases when numerous sequence alignments are not well constructed. This has significant implications for drug discovery. Based on the Mamba architecture, researchers provide ProtMamba, a homology-aware yet alignment-free protein language model. ProtMamba, a unique attention-based model, handles hundreds of protein sequences…
In drug discovery, the accurate prediction of chemical activities is paramount. The conventional forms of QSAR that were initially developed and widely used are the traditional or classical approach of QSAR modeling. However, there is a fundamentally new approach that redefines the future of data completion in drug discovery, called QSAR-Complete (QComp), developed by the…
In the drug discovery process, high-throughput screening quickly evaluates a wide range of chemical compounds to find hit compounds for certain biological targets. False-positive results, on the other hand, cause delays in hit compound screening and waste money. In order to address this, scientists from Central South University, China, and collaborators have developed ChemFH, an…
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
